BCAT1 anticorps
-
- Antigène Voir toutes BCAT1 Anticorps
- BCAT1 (Branched Chain Amino-Acid Transaminase 1, Cytosolic (BCAT1))
-
Reactivité
- Humain, Souris, Chien
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp BCAT1 est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC)
- Attributs du produit
- Homo sapiens branched chain amino-acid transaminase 1, cytosolic (BCAT1), transcript variant 1
- Purification
- Purified from mouse ascites fluids by affinity chromatography
- Immunogène
- Full length human recombinant protein of human BCAT1(NP_005495) produced in HEK293T cell.
- Clone
- 3F5
- Isotype
- IgG2a
- Top Product
- Discover our top product BCAT1 Anticorps primaire
-
-
- Indications d'application
- WB 1:500~2000, IHC 1:150,
- Commentaires
-
The concentration of the product may vary between diferrent lots.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.5-1.0 mg/mL
- Buffer
- PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
-
-
BCAT1 is a New MR Imaging-related Biomarker for Prognosis Prediction in IDH1-wildtype Glioblastoma Patients." dans: Scientific reports, Vol. 7, Issue 1, pp. 17740, (2017) (PubMed).
: "Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia." dans: Nature, Vol. 545, Issue 7655, pp. 500-504, (2017) (PubMed).
: "
-
BCAT1 is a New MR Imaging-related Biomarker for Prognosis Prediction in IDH1-wildtype Glioblastoma Patients." dans: Scientific reports, Vol. 7, Issue 1, pp. 17740, (2017) (PubMed).
-
- Antigène
- BCAT1 (Branched Chain Amino-Acid Transaminase 1, Cytosolic (BCAT1))
- Autre désignation
- BCAT1 (BCAT1 Produits)
- Synonymes
- anticorps fj66g02, anticorps zgc:73157, anticorps wu:fj66g02, anticorps Bcatc, anticorps BCATC, anticorps BCT1, anticorps ECA39, anticorps MECA39, anticorps PNAS121, anticorps PP18, anticorps BCATc, anticorps Eca39, anticorps branched chain amino-acid transaminase 1, cytosolic, anticorps branched chain amino acid transaminase 1, anticorps branched chain amino-acid transaminase 1, cytosolic L homeolog, anticorps branched chain aminotransferase 1, cytosolic, anticorps bcat1, anticorps BCAT1, anticorps bcat1.L, anticorps Bcat1
- Sujet
- This gene encodes the cytosolic form of the enzyme branched-chain amino acid transaminase. This enzyme catalyzes the reversible transamination of branched-chain alpha-keto acids to branched-chain L-amino acids essential for cell growth. Two different clinical disorders have been attributed to a defect of branched-chain amino acid transamination: hypervalinemia and hyperleucine-isoleucinemia. As there is also a gene encoding a mitochondrial form of this enzyme, mutations in either gene may contribute to these disorders. Alternatively spliced transcript variants have been described.
- Poids moléculaire
- 42.8 kDa
- ID gène
- 586
- NCBI Accession
- NM_005504
- HGNC
- 586
-